3,17-Dioxa-10,24,30,31-tetrathia-7,14,21,28,33,34,35,36-octaazahexacyclo[13.13.4.12,5.19,12.116,19.123,26]hexatriaconta-2(36),9(35),11,16(34),23(33),25-hexaene-6,13,20,27-tetrone,4,18-dimethyl-8,22-bis(2-methylpropyl)-, (1R,4R,5S,8R,15R,18R,19S,22R)-,74847-09-9 Products Supply

Name: 3,17-Dioxa-10,24,30,31-tetrathia-7,14,21,28,33,34,35,36-octaazahexacyclo[13.13.4.12,5.19,12.116,19.123,26]hexatriaconta-2(36),9(35),11,16(34),23(33),25-hexaene-6,13,20,27-tetrone,4,18-dimethyl-8,22-bis(2-methylpropyl)-, (1R,4R,5S,8R,15R,18R,19S,22R)-
CAS NO.: 74847-09-9
Synonyms:
Ulithiacyclamide;3,17-Dioxa-10,24,30,31-tetrathia-7,14,21,28,33,34,35,36-octaazahexacyclo[13.13.4.12,5.19,12.116,19.123,26]hexatriacontane,ulithiacyclamide deriv.;3,17-Dioxa-10,24,30,31-tetrathia-7,14,21,28,33,34,35,36-octaazahexacyclo[13.13.4.12,5.19,12.116,19.123,26]hexatriaconta-2(36),9(35),11,16(34),23(33),25-hexaene-6,13,20,27-tetrone,4,18-dimethyl-8,22-bis(2-methylpropyl)-,[1R-(1R*,4R*,5S*,8R*,15R*,18R*,19S*,22R*)]-; NSC 348113;[1R-(1R*,4R*,5S*,8R*,15R*,18R*,19S*,22R*)]-4,18-Dimethyl-8,22-bis(2-methylpropyl)-3,17-dioxa-10,24,30,31-tetrathia-7,14,21,28,33,34,35,36-octaazahexacyclo[13.13.4.12,5.19,12.116,19.123,26]hexatriaconta-2(36),9(35),11,16(34),23(33),25-hexaene-6,13,20,27-tetrone
Molecular Structure:
Molecular Formula: C32H42 N8 O6 S4

Send a message direct to supplier(s)*

Please post your buying leads,so that our qualified suppliers will soon contact you!

CAS NO.：
* Purchase Request：

* Your Email：
* Name：
* Gender：	Male Female
* Country/Area：
* Company Name：
* Tel：	- - Country - Code Area - Code Number

* Message：

Related products: 3,17-Dioxa-10,24,30,31-tetrath; 3,17-Dioxa-10,24,30,31-tetrath; 1/C33H42O7/c1-19-25-17-24-18-2; 1/C28H41N5O15S.Na/c1-12(2)21(2; 1/C51H74N2/c1-5-9-13-17-21-49(; 1/C27H27N3O3S/c1-30-25(20-11-1; 1/C26H18O2/c1-17-16-23-21-9-5-; 1/C22H28O6/c1-23-17-11-21(27-5; 1/C21H26N2O4/c1-3-14-8-9-19(25; 11',29'-di-tert-butyl-5',17',2; 1/C30H52/c1-10-25(6)16-12-20-3; 1/C23H22N2O2/c26-23(27-22-15-2; 1/C19H15ClN2O2S/c1-11-19(23)24; (2R,3R)-N-{(1'S,2S,7'R,9'Z,17'; Neuropeptide Y (human),24-L-le; 1/C18H18O6/c1-22-14-8-13(20)15; 1/C17H22N6/c1-2-8-19-13-11-14(; 1/C19H20O5/c1-11(2)7-18(21)24-; Cecropin A (Platysamiacecropia; (1S,15R)-10,21,26-trimethoxy-3; 1/C19H24N2O2/c1-12(2)14-8-6-9-; 1/C18H19NO4/c1-22-15-8-11-10(7; Spiro[cyclohexane-1,2'-[9,4](e; 10,15,26-trimethoxy-4,20-dimet; 10,14,15-trimethoxy-20-methyl-; 1/C20H20N2/c1-4-10-16(11-5-1)1; Somatoliberin (human pancreati; Spiro[cyclopentane-1,2'-[9,4](; 1/C18H30O4/c1-4-5-6-7-15(19)13; 1/C14H13N7O/c1-8-12(21-14(17)1;